Stay updated on Daratumumab Dose Schedules in Smoldering Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Dose Schedules in Smoldering Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Dose Schedules in Smoldering Multiple Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added the disease keyword 'Multiple myeloma' and a related topics link 'MedlinePlus Genetics' to the study page. This improves categorization and connects visitors with relevant background resources.
    Difference
    0.1%
    Check dated 2026-06-22T23:09:48.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now indicates the study is not recruiting anymore, reflecting closure of enrollment. A content/navigation refresh added new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and removed older topics (Intervention / Treatment, related topics, MedlinePlus Genetics, Revision: v3.5.5).
    Difference
    0.4%
    Check dated 2026-06-15T18:40:44.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5, indicating a minor update to the page or its underlying system. No study content or data were changed as a result of this revision.
    Difference
    0.0%
    Check dated 2026-06-08T15:16:22.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics to the study page, expanding contextual links and resources.
    Difference
    0.1%
    Check dated 2026-05-25T07:46:31.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added a new revision label 'Revision: v3.5.4'. Removed the core disease term 'Multiple myeloma' and related topics such as 'MedlinePlus Genetics', as well as the previous revision label 'Revision: v3.5.3'.
    Difference
    0.1%
    Check dated 2026-05-18T03:52:07.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The study record’s results section was updated to show newly posted study results (dated 2026-04-23) and corresponding changes to multiple outcome measures. These include efficacy endpoints like complete response by IMWG, MRD negativity, progression/death and PFS measures, time to next treatment, response to first subsequent treatment, symptomatic progression with adverse prognostic features, and overall survival definitions/figures.
    Difference
    2%
    Check dated 2026-04-26T15:34:46.000Z thumbnail image

Stay in the know with updates to Daratumumab Dose Schedules in Smoldering Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Dose Schedules in Smoldering Multiple Myeloma Clinical Trial page.